Development of a new generation of propofol
- PMID: 17620837
- DOI: 10.1097/ACO.0b013e3281667777
Development of a new generation of propofol
Abstract
Purpose of review: The current advance in development of a new generation of propofol and its clinical implications are reviewed.
Recent findings: All currently available formulations of propofol have side effects related to propofol itself, as well as to the emulsion delivery systems. A search for better and safer propofol continues. Improvement of the emulsion delivery systems is one of approaches, which can be achieved by identifying better inactive components, enhancing stability, and applying new technologies such as nanotechnology. Modification of chemical structure is another approach, particularly with the development of propofol prodrugs.
Summary: There is a continuous need to develop a better and safer propofol. The development of a new propofol should be focused on minimizing the unwanted side effects, while preserving the beneficial profiles. Hopefully, just such a new propofol will be available in the near future for clinical use.
Similar articles
-
Propofol: the challenges of formulation.Anesthesiology. 2005 Oct;103(4):860-76. doi: 10.1097/00000542-200510000-00026. Anesthesiology. 2005. PMID: 16192780 Review.
-
Free radical and drug oxidation products in an intensive care unit sedative: propofol with sulfite.Crit Care Med. 2003 Mar;31(3):787-92. doi: 10.1097/01.CCM.0000053560.05156.73. Crit Care Med. 2003. PMID: 12626985
-
New drug, fospropofol disodium: a propofol prodrug.AANA J. 2009 Aug;77(4):301-8. AANA J. 2009. PMID: 19731849 Review.
-
Comparative propofol emulsion stabilities.AANA J. 2000 Aug;68(4):287. AANA J. 2000. PMID: 11125598 No abstract available.
-
Sulfite-induced propofol oxidation: a cause for radical concern.Crit Care Med. 2003 Mar;31(3):981-3. doi: 10.1097/01.CCM.0000053526.68271.CD. Crit Care Med. 2003. PMID: 12627021 Review. No abstract available.
Cited by
-
Perspectives on the role of fospropofol in the monitored anesthesia care setting.Anesthesiol Res Pract. 2011;2011:458920. doi: 10.1155/2011/458920. Epub 2011 Apr 14. Anesthesiol Res Pract. 2011. PMID: 21541247 Free PMC article.
-
The future of anaesthesiology.Indian J Anaesth. 2012 Nov;56(6):524-8. doi: 10.4103/0019-5049.104567. Indian J Anaesth. 2012. PMID: 23325935 Free PMC article.
-
Disruption of biological membranes by hydrophobic molecules: a way to inhibit bacterial growth.Front Microbiol. 2025 Jan 8;15:1478519. doi: 10.3389/fmicb.2024.1478519. eCollection 2024. Front Microbiol. 2025. PMID: 39845054 Free PMC article.
-
Sub-anaesthetic dose of propofol attenuates mechanical allodynia in chronic post-ischaemic pain via regulation of PTEN/PI3K/IL-6 signalling.Mol Pain. 2023 Jan-Dec;19:17448069231185232. doi: 10.1177/17448069231185232. Mol Pain. 2023. PMID: 37314769 Free PMC article.
-
Halothane: Is there still any place for using the gas as an anesthetic?Hepat Mon. 2011 Jul;11(7):511-2. Hepat Mon. 2011. PMID: 22087187 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials